Peters, K., Kirkpatrick, J., Batinic-Haberle, I., Affronti, M., Woodring, S., Iden, D., … Crapo, J. (2018). PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS. In NEURO-ONCOLOGY (Vol. 20, pp. 1vi7-vi17). New Orleans, LA: OXFORD UNIV PRESS INC. https://doi.org/10.1093/neuonc/noy148.061

Peters, Katherine, John Kirkpatrick, Ines Batinic-Haberle, Mary Affronti, Sarah Woodring, Deborah Iden, Sujata Panta, et al. “PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS.” In NEURO-ONCOLOGY, 20:1vi7-vi17. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.061.

Peters K, Kirkpatrick J, Batinic-Haberle I, Affronti M, Woodring S, Iden D, et al. PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 1vi7-vi17.

Peters, Katherine, et al. “PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS.” NEURO-ONCOLOGY, vol. 20, no. suppl. 6; abstr QOLP-13, OXFORD UNIV PRESS INC, 2018, pp. 1vi7-vi17. Manual, doi:10.1093/neuonc/noy148.061.

Peters K, Kirkpatrick J, Batinic-Haberle I, Affronti M, Woodring S, Iden D, Panta S, Lipp E, Healy P, Herndon J, Spasojevic I, Penchev S, Gad S, Siberstein D, Johnson M, Randazzo D, Desjardins A, Friedman H, Ashley D, Crapo J. PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 1vi7-vi17.